DRUG DISCOVERY AI FACTORY
LIVE

Serial Number

79393432

Owner

FRONTEO, Inc.

Attorney

Tomoko Nakajima

Filing Date

Dec 13, 2023

Add to watchlist:

No watchlists yet
View on USPTO

DRUG DISCOVERY AI FACTORY Trademark

Serial Number: 79393432 • Registration: 7665758

DRUG DISCOVERY AI FACTORY is a trademark filed by FRONTEO, Inc. on December 13, 2023. The trademark is classified under Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

FRONTEO, Inc. (17 trademarks)

2-12-23 Kounan,

Entity Type: 03

Trademark Details

Filing Date

December 13, 2023

Registration Date

January 28, 2025

Published for Opposition

December 10, 2024

Goods & Services

Providing information on educational and instruction services relating to medicine and pharmaceuticals; arranging and conducting seminars relating to medicine and pharmaceuticals; instruction services in the field of pharmaceuticals

Compilation of information into computer databases for research in the field of pharmaceuticals

Downloadable computer programs for selecting target molecules and genes for the purpose of developing and creating drugs; downloadable computer programs for hypothesis generation regarding some relationships between target molecules and diseases for the purpose of developing and creating drugs; downloadable computer programs for hypothesis generation regarding some relationships between genes and diseases for the purpose of developing and creating drugs; downloadable computer programs for proposing and searching indications; downloadable computer programs for hypothesis generation regarding some relationships between certain modalities and their indications; devices for analyzing electronic images; downloadable computer programs for data processing; devices for data processing; computer hardware for data processing

Providing on-line non-downloadable computer programs for selecting target molecules and genes for the purpose of developing and creating drugs; providing on-line non-downloadable computer programs for hypothesis generation regarding some relationships between target molecules and diseases for the purpose of developing and creating drugs; providing on-line non-downloadable computer programs for hypothesis generation regarding some relationships between genes and diseases for the purpose of developing and creating drugs; providing on-line non-downloadable computer programs for proposing and searching indications; providing on-line non-downloadable computer programs for hypothesis generation regarding some relationships between certain modalities and their indications; provision of information search engines via internet; designing and creating services of home pages and websites; designing, programming, and maintenance of computer programs for selecting target molecules and genes for the purpose of developing and creating drugs; designing, programming, and maintenance of computer programs for hypothesis generation regarding some relationships between target molecules and diseases for the purpose of developing and creating drugs; designing, programming, and maintenance of computer programs for hypothesis generation regarding some relationships between genes and diseases for the purpose of developing and creating drugs; designing, programming, and maintenance of computer programs for proposing and searching indications; designing, programming, and maintenance of computer programs for hypothesis generation regarding some relationships between certain modalities and their indications; scientific testing, inspection and research for making a hypothesis on relationships between genes and diseases; testing, inspection or research of pharmaceuticals; consulting services relating to testing, inspection and research of pharmaceuticals; providing information on research of pharmaceuticals; drug discovery services; research and scientific inspection of pharmaceuticals relating to genetic analysis; scientific testing and research on health equipment; rental of measuring and testing instruments; rental of measuring apparatus; hosting web portals on the Internet; rental of server memory space for social networking websites; rental of computers

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Dec 11, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 26, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Nov 26, 2025 OPNR
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 5, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 15, 2025 FICS
FINAL DISPOSITION PROCESSED
Aug 15, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 29, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 28, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 28, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 10, 2024 NPUB
PUBLISHED FOR OPPOSITION
Dec 10, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 4, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 14, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 4, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 4, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 4, 2024 TROA
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Sep 18, 2024 CORN
REFUSAL PROCESSED BY IB
Aug 25, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 7, 2024 RFCS
REFUSAL PROCESSED BY MPU
Aug 7, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 21, 2024 RFCR
NON-FINAL ACTION WRITTEN
Jul 20, 2024 CNRT
ASSIGNED TO EXAMINER
Jul 11, 2024 DOCK
CORRECTION TRANSACTION RECEIVED FROM IB
Jun 30, 2024 CRCV
APPLICATION FILING RECEIPT MAILED
Apr 23, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 18, 2024 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Apr 16, 2024 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 11, 2024 REPR